HALOVSSXTC• 6 Months (Normalized)
HALO vs SXTC (Halozyme Therapeutics Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.72
+63.57%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
SXTC Performance $1.25
-99.25%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+162.82 pts
HALO outperforming by 162.82 percentage points
HALOSXTC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | HALO Price | HALO Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $109.72 | +63.57% | $1.25 | -99.25% | +162.82% |
| Oct 05, 2026 | $108.31 | +61.46% | $2.08 | -98.74% | +160.20% |
| Oct 02, 2026 | $109.86 | +63.77% | $2.41 | -98.54% | +162.31% |
| Oct 01, 2026 | $106.94 | +59.42% | $2.96 | -98.21% | +157.63% |
| Sep 30, 2026 | $110.40 | +64.58% | $3.01 | -98.18% | +162.76% |
| Sep 29, 2026 | $111.56 | +66.31% | $2.81 | -98.30% | +164.61% |
| Sep 28, 2026 | $112.89 | +68.29% | $2.52 | -98.48% | +166.77% |
| Sep 25, 2026 | $113.90 | +69.80% | $- | - | |
| Sep 23, 2026 | $112.44 | +67.62% | $2.51 | -98.48% | +166.10% |
| Sep 22, 2026 | $115.13 | +71.63% | $- | - | |
| Sep 21, 2026 | $111.45 | +66.14% | $2.38 | -98.56% | +164.70% |
| Sep 18, 2026 | $112.45 | +67.64% | $2.40 | -98.55% | +166.19% |
| Sep 17, 2026 | $109.68 | +63.51% | $2.44 | -98.53% | +162.04% |
| Sep 16, 2026 | $108.44 | +61.66% | $2.19 | -98.68% | +160.34% |
| Sep 15, 2026 | $106.25 | +58.39% | $2.36 | -98.57% | +156.96% |
Page 1 of 9